24 related articles for article (PubMed ID: 1505133)
1. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.
Vallejos V; Balaña C; Fraile M; Roussos Y; Capellades J; Cuadras P; Ballester R; Ley A; Arellano A; Rosell R
J Neurooncol; 2002 Aug; 59(1):81-90. PubMed ID: 12222842
[TBL] [Abstract][Full Text] [Related]
2. 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas.
Kallén K; Burtscher IM; Holtås S; Ryding E; Rosén I
J Neurooncol; 2000; 46(2):173-85. PubMed ID: 10894370
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT.
Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E; Rosén I
J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):569-74. PubMed ID: 9408094
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours.
Dierckx RA; Martin JJ; Dobbeleir A; Crols R; Neetens I; De Deyn PP
Eur J Nucl Med; 1994 Jul; 21(7):621-33. PubMed ID: 7957348
[TBL] [Abstract][Full Text] [Related]
5. 99Tcm-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and 201Tl SPECT).
Rodrigues M; Fonseca AT; Salgado D; Vieira MR
Nucl Med Commun; 1993 Dec; 14(12):1050-60. PubMed ID: 8295760
[TBL] [Abstract][Full Text] [Related]
6. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
7. Tl-201 and Tc-99m HMPAO SPECT in a patient with recurrent thymoma.
Ohta H; Taniguchi T; Watanabe H; Komibuchi T; Nakade M; Kohno K
Clin Nucl Med; 1996 Nov; 21(11):902-3. PubMed ID: 8922866
[No Abstract] [Full Text] [Related]
8. Discordant technetium-99m HMPAO and thallium-201 chloride distribution in brain tumors.
Kamisaki Y; Seto H; Nagayoshi T; Kageyama M; Shimizu M; Wu YW; Watanabe N; Kakishita M
Radiat Med; 1996; 14(3):155-8. PubMed ID: 8827811
[TBL] [Abstract][Full Text] [Related]
9. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors.
O'Tuama LA; Janicek MJ; Barnes PD; Scott RM; Black PM; Sallan SE; Tarbell NJ; Kupsky WJ; Wagenaar D; Ulanski JS
Pediatr Neurol; 1991; 7(4):249-57. PubMed ID: 1930415
[TBL] [Abstract][Full Text] [Related]
10. Dual isotope SPECT in the evaluation of recurrent brain tumor.
Zhang JJ; Park CH; Kim SM; Ayyangar KM; Haghbin M
Clin Nucl Med; 1992 Aug; 17(8):663-4. PubMed ID: 1505133
[TBL] [Abstract][Full Text] [Related]
11. The clinical role of SPECT in patients with brain tumors.
Holman BL; Abdel-Dayem H
J Neuroimaging; 1995 Jul; 5 Suppl 1():S34-9. PubMed ID: 7626835
[No Abstract] [Full Text] [Related]
12. Functional imaging using PET and SPECT in pediatric neurology.
Messa C; Grana C; Lucignani G; Fazio F
J Nucl Biol Med (1991); 1994 Mar; 38(1):85-8. PubMed ID: 8075181
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
